Oncology Institute (NASDAQ:TOI) Issues Quarterly Earnings Results, Misses Estimates By $0.06 EPS

Oncology Institute (NASDAQ:TOI) announced its quarterly earnings results on Monday. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.06), Zacks reports. Oncology Institute had a negative return on equity of 186.83% and a negative net margin of 17.63%. The business had revenue of $100.27 million for the quarter, compared to the consensus estimate of $109.15 million. Oncology Institute updated its FY 2025 guidance to EPS.

Oncology Institute Price Performance

Shares of TOI stock opened at $1.24 on Tuesday. The stock’s fifty day simple moving average is $0.80 and its 200 day simple moving average is $0.46. Oncology Institute has a one year low of $0.13 and a one year high of $1.89. The firm has a market cap of $93.69 million, a price-to-earnings ratio of -1.59 and a beta of 0.41. The company has a debt-to-equity ratio of 5.91, a current ratio of 2.49 and a quick ratio of 2.27.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.